CL2016001648A1 - Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento; composición farmacéutica y veterinaria que los comprende; método para inducir cardioprotección, neuroprotección, control del apetito, y método para estimular el crecimiento y resistencia a enfermedades en organismos acuáticos. (divisional de solicitud 2007-00528). - Google Patents
Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento; composición farmacéutica y veterinaria que los comprende; método para inducir cardioprotección, neuroprotección, control del apetito, y método para estimular el crecimiento y resistencia a enfermedades en organismos acuáticos. (divisional de solicitud 2007-00528).Info
- Publication number
- CL2016001648A1 CL2016001648A1 CL2016001648A CL2016001648A CL2016001648A1 CL 2016001648 A1 CL2016001648 A1 CL 2016001648A1 CL 2016001648 A CL2016001648 A CL 2016001648A CL 2016001648 A CL2016001648 A CL 2016001648A CL 2016001648 A1 CL2016001648 A1 CL 2016001648A1
- Authority
- CL
- Chile
- Prior art keywords
- diseases
- pharmaceutical
- growth
- resistance
- neuroprotection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
<p>COMPUESTOS ANÁLOGOS A LOS SECRETAGOGOS PEPTIDICOS DE LA HORMONA DEL CRECIMIENTO; COMPOSICIÓN FARMACÉUTICA Y VETERINARIA QUE LOS COMPRENDE; Y MÉTODO PARA ESTIMULAR EL CRECIMIENTO Y RESISTENCIA A ENFERMEDADES EN ORGANISMOS ACUÁTICOS (DIVISIONAL DE SOL. N° 528-07).</p>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060050A CU23558A1 (es) | 2006-02-28 | 2006-02-28 | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2016001648A1 true CL2016001648A1 (es) | 2017-02-24 |
Family
ID=40130780
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2007000528A CL2007000528A1 (es) | 2006-02-28 | 2007-02-27 | Compuestos analogos a los secretagogos peptidicos de la hormona del crecimiento; composicion farmaceutica y veterinaria que los comprende; metodo para inducir cardioproteccion, neuroproteccion, control del apetito, y metodo para estimular el crecimiento y resistencia a enfermedades en organismos acuaticos. |
CL2016001648A CL2016001648A1 (es) | 2006-02-28 | 2016-06-24 | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento; composición farmacéutica y veterinaria que los comprende; método para inducir cardioprotección, neuroprotección, control del apetito, y método para estimular el crecimiento y resistencia a enfermedades en organismos acuáticos. (divisional de solicitud 2007-00528). |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2007000528A CL2007000528A1 (es) | 2006-02-28 | 2007-02-27 | Compuestos analogos a los secretagogos peptidicos de la hormona del crecimiento; composicion farmaceutica y veterinaria que los comprende; metodo para inducir cardioproteccion, neuroproteccion, control del apetito, y metodo para estimular el crecimiento y resistencia a enfermedades en organismos acuaticos. |
Country Status (18)
Country | Link |
---|---|
US (1) | US8367620B2 (es) |
EP (1) | EP1997827B1 (es) |
JP (1) | JP5183496B2 (es) |
KR (1) | KR101409277B1 (es) |
CN (1) | CN101432294B (es) |
AR (1) | AR059646A1 (es) |
AU (1) | AU2007219569B2 (es) |
BR (1) | BRPI0708366A2 (es) |
CA (1) | CA2637593C (es) |
CL (2) | CL2007000528A1 (es) |
CU (1) | CU23558A1 (es) |
ES (1) | ES2441441T3 (es) |
MX (1) | MX2008011142A (es) |
MY (1) | MY184130A (es) |
NO (1) | NO20084118L (es) |
RU (1) | RU2416618C2 (es) |
WO (1) | WO2007098716A1 (es) |
ZA (1) | ZA200807162B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010052828A1 (ja) * | 2008-11-06 | 2010-05-14 | 国立大学法人名古屋大学 | 非虚血性心筋障害に対する医薬 |
CU24473B1 (es) * | 2016-11-01 | 2020-02-04 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal |
RU2734835C1 (ru) * | 2020-02-11 | 2020-10-23 | Федеральное государственное бюджетное учреждение науки Лимнологический институт Сибирского отделение Российской академии наук (ЛИН СО РАН) | Способ повышения жизнестойкости эмбрионов рыб в аквакультуре |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3239345A (en) | 1965-02-15 | 1966-03-08 | Estrogenic compounds and animal growth promoters | |
US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4036979A (en) | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
DE68922602T2 (de) | 1988-01-28 | 1995-12-07 | Polygen Holding Corp | Polypeptide mit hormonwachstumsbefreiender wirkung. |
EP0398961B1 (en) | 1988-01-28 | 1994-11-02 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
JP2670680B2 (ja) | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
ATE133073T1 (de) | 1990-10-25 | 1996-02-15 | Genentech Inc | Verwendung gegen reaktive sauerstoffverbindungen schützender wirkstoffe |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
US5726319A (en) | 1992-11-06 | 1998-03-10 | Merck & Co., Inc. | Biphenyl substituted dipeptide analogs promote release of growth hormone |
CA2147503A1 (en) | 1992-11-06 | 1994-05-26 | Judith M. Pisano | Substituted dipeptide analogs promote release of growth hormone |
US5578593A (en) | 1992-12-11 | 1996-11-26 | Merck & Co., Inc. | Spiro piperidines and homologs promote release of growth hormone |
RU2168512C2 (ru) | 1992-12-11 | 2001-06-10 | Мерк Энд Ко., Инк. | Спиропиперидины, способы их получения (варианты) |
WO1995011029A1 (en) | 1993-10-19 | 1995-04-27 | Merck & Co., Inc. | Combination of bisphosphonates and growth hormone secretagogues |
US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5492916A (en) | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
EP0739204A4 (en) | 1993-11-09 | 2000-03-15 | Merck & Co Inc | PIPERIDINE, PYRROLIDINE AND HEXAHYDRO-1H-AZEPINE SUPPORT THE RELEASE OF THE GROWTH HORMONE |
WO1995014666A1 (en) | 1993-11-24 | 1995-06-01 | Merck & Co., Inc. | Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
US5721251A (en) | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
US5721250A (en) | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
WO1995017423A1 (en) | 1993-12-23 | 1995-06-29 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
CA2179598A1 (en) | 1993-12-23 | 1995-06-29 | Nils Langeland Johansen | Compounds with growth hormone releasing properties |
WO1995034311A1 (en) | 1994-06-13 | 1995-12-21 | Merck & Co., Inc. | Piperazine compounds promote release of growth hormone |
WO1996002530A1 (en) | 1994-07-20 | 1996-02-01 | Merck & Co., Inc. | Piperidines and hexahydro-1h-azepines spiro substituted at the 4-position promote release of growth hormone |
US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
WO1996022996A1 (fr) | 1995-01-25 | 1996-08-01 | Nippon Chemiphar Co., Ltd. | Derives de dihydrophenazine |
IL116923A (en) | 1995-01-27 | 2000-09-28 | Novo Nordisk As | Compounds with growth hormone releasing properties and pharmaceutical compositions containing them |
AU4534596A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU4534696A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US5559128A (en) | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
AU5486396A (en) | 1995-04-19 | 1996-11-07 | Merck & Co., Inc. | Process for the preparation of spiroindolines |
WO1996035713A1 (en) | 1995-05-08 | 1996-11-14 | Pfizer, Inc. | Dipeptides which promote release of growth hormone |
DE69533991T2 (de) | 1995-05-29 | 2006-04-13 | Pfizer Inc. | Dipeptide, die die ausschüttung von wachstumshormonen stimulieren |
HUP9802821A3 (en) | 1995-06-22 | 2000-03-28 | Novo Nordisk As | Compounds with growth hormone releasing properties |
AU6772996A (en) | 1995-08-21 | 1997-03-12 | Eli Lilly And Company | 2-acylaminopropanamides as growth hormone secretagogues |
WO1997007117A1 (en) | 1995-08-21 | 1997-02-27 | Eli Lilly And Company | 2-acylaminopropanamines as growth hormone secretagogues |
EP0766966A3 (en) | 1995-09-08 | 2001-02-28 | Eli Lilly And Company | Method of treating insulin resistance |
AU7169696A (en) | 1995-09-26 | 1997-04-17 | Merck & Co., Inc. | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
US5723616A (en) | 1995-10-27 | 1998-03-03 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
US5767124A (en) | 1995-10-27 | 1998-06-16 | Merck & Co., Inc. | Polymorphic forms of a growth hormone secretagogue |
WO1997015191A1 (en) | 1995-10-27 | 1997-05-01 | Merck & Co., Inc. | Wet granulation formulation of a growth hormone secretagogue |
AU7468596A (en) | 1995-10-27 | 1997-05-15 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
JP3798024B2 (ja) | 1995-12-13 | 2006-07-19 | メルク エンド カンパニー インコーポレーテッド | 成長ホルモン分泌促進物質レセプターアッセイ |
ES2229289T3 (es) | 1995-12-13 | 2005-04-16 | MERCK & CO., INC. | Familia de receptores de secretagogo de la hormona del crecimiento. |
IT1277113B1 (it) | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
WO1997022367A1 (en) | 1995-12-20 | 1997-06-26 | Merck & Co., Inc. | Radiolabeled growth hormone secretagogue |
PL327227A1 (en) | 1995-12-22 | 1998-12-07 | Novo Nordisk As | Compounds exhibiting growth hormone liberating properties |
TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
AU2334097A (en) | 1996-03-21 | 1997-10-10 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
AU2722297A (en) | 1996-04-03 | 1997-10-22 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
AU2382097A (en) | 1996-04-19 | 1997-11-12 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
CA2252761A1 (en) | 1996-04-24 | 1997-10-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US5919777A (en) | 1996-04-24 | 1999-07-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
WO1997041878A1 (en) | 1996-05-07 | 1997-11-13 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
CA2253390A1 (en) | 1996-05-07 | 1997-11-13 | Merck & Co., Inc. | Enhancement of sleep with a growth hormone secretagogue |
JP2001525793A (ja) | 1996-05-14 | 2001-12-11 | ノボ ノルディスク アクティーゼルスカブ | ソマトスタチンの作動因子及び拮抗因子 |
AU3220097A (en) | 1996-05-22 | 1997-12-09 | Arch Development Corporation | Sleep quality improvement using a growth hormone secretagogue |
HUP9904049A3 (en) | 1996-05-31 | 2000-07-28 | Novo Nordisk As | Growth hormone component and bone anti-resorptive agent in cyclic(coherence)treatment of osteoporosis |
AU3434697A (en) | 1996-07-22 | 1998-02-10 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
WO1998010653A1 (en) | 1996-09-13 | 1998-03-19 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
WO1998018815A1 (en) | 1996-10-25 | 1998-05-07 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
SE9703929D0 (sv) | 1996-11-22 | 1997-10-28 | Pharmacia & Upjohn Ab | Therapeutical use and method |
WO1998046569A1 (fr) | 1997-04-11 | 1998-10-22 | Sumitomo Pharmaceuticals Co., Ltd. | Derives de benzene |
JP2000514838A (ja) | 1997-05-14 | 2000-11-07 | 藤沢薬品工業株式会社 | 成長ホルモンの放出を促進するピペリジノ誘導体 |
US5861149A (en) | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
AU7906998A (en) | 1997-06-20 | 1999-01-04 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
UA53716C2 (uk) | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
AU7445498A (en) | 1997-06-25 | 1999-01-04 | Pfizer Inc. | Dipeptide derivatives as growth hormone secretagogues |
UA64751C2 (uk) | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
ZA987383B (en) | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
ES2275313T3 (es) | 1997-08-22 | 2007-06-01 | Kaken Pharmaceutical Co., Ltd. | Derivados de amida como promotores de la liberacion de la hormona del crecimiento. |
DE69921611T2 (de) | 1998-01-16 | 2005-11-03 | Novo Nordisk A/S | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
WO1999039730A1 (fr) | 1998-02-09 | 1999-08-12 | Kaken Pharmaceutical Co., Ltd. | Preparation a administration orale contenant des peptides favorisant la secretion d'hormone de croissance |
AU3247899A (en) | 1998-03-03 | 1999-09-20 | Novo Nordisk A/S | New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide |
HUP0102071A3 (en) | 1998-05-11 | 2002-06-28 | Novo Nordisk As | 3,3- and 4,4-disubstituted piperidine derivatives with growth hormone releasing properties and pharmaceutical compositions containing them |
WO1999064456A1 (en) | 1998-06-09 | 1999-12-16 | Novo Nordisk A/S | A method for preparing a compound with growth hormone releasing properties |
CA2335112A1 (en) | 1998-06-16 | 1999-12-23 | Hua Zhu Ke | Therapeutic combinations for musculoskeletal frailty |
AP9901582A0 (en) | 1998-06-16 | 1999-06-30 | Pfizer Prod Inc | Combination therapy for musculoskeletal frailty. |
IL140044A0 (en) | 1998-06-30 | 2002-02-10 | Novo Nordisk As | Compounds with growth hormone releasing properties |
AU5301199A (en) | 1998-08-20 | 2000-03-14 | Sumitomo Pharmaceuticals Company, Limited | Oxindole derivatives as growth hormone releasers |
US6358951B1 (en) | 1998-08-21 | 2002-03-19 | Pfizer Inc. | Growth hormone secretagogues |
AU2405401A (en) | 1999-12-28 | 2001-07-09 | Kaken Pharmaceutical Co., Ltd. | Nerve protective drugs |
CA2411667A1 (en) | 2000-05-30 | 2001-12-06 | Merck & Co. Inc. | Ghrelin analogs |
EP1159964B1 (en) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating gastrointestinal motility |
NZ522280A (en) | 2000-06-13 | 2004-09-24 | Zentaris Ag | Growth hormone secretagogues |
CA2413252A1 (en) | 2000-06-23 | 2002-12-20 | Takahiko Murata | Preventives or remedies for heart failure |
ITMI20011445A1 (it) | 2001-07-06 | 2003-01-06 | Europ Geie | Analoghi della cortistantina capaci di legarsi selettivamente ai recettori dei secretagoghi dell'ormone della crescita |
HK1077740A1 (en) | 2001-12-20 | 2006-02-24 | Ct Ingenieria Genetica Biotech | Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
WO2005039625A1 (en) | 2003-10-28 | 2005-05-06 | Rheoscience A/S | Growth hormone secretagogue receptor agonists |
JP2007510662A (ja) | 2003-11-04 | 2007-04-26 | エリクシアー ファーマシューティカルズ, インコーポレイテッド | 治療化合物およびその使用 |
WO2005048916A2 (en) | 2003-11-20 | 2005-06-02 | Biovitrum Ab | Tetrahydrospiro-beta-carboline-1,3 '-pyrrolidine derivatives and their use in ghsr-related disorders |
-
2006
- 2006-02-28 CU CU20060050A patent/CU23558A1/es active IP Right Grant
-
2007
- 2007-02-27 CL CL2007000528A patent/CL2007000528A1/es unknown
- 2007-02-27 AR ARP070100806A patent/AR059646A1/es not_active Application Discontinuation
- 2007-02-28 KR KR1020087023543A patent/KR101409277B1/ko not_active IP Right Cessation
- 2007-02-28 BR BRPI0708366-1A patent/BRPI0708366A2/pt not_active IP Right Cessation
- 2007-02-28 AU AU2007219569A patent/AU2007219569B2/en not_active Ceased
- 2007-02-28 MY MYPI20083178A patent/MY184130A/en unknown
- 2007-02-28 CN CN2007800153594A patent/CN101432294B/zh not_active Expired - Fee Related
- 2007-02-28 US US12/281,085 patent/US8367620B2/en not_active Expired - Fee Related
- 2007-02-28 CA CA2637593A patent/CA2637593C/en not_active Expired - Fee Related
- 2007-02-28 JP JP2008556643A patent/JP5183496B2/ja not_active Expired - Fee Related
- 2007-02-28 EP EP07711101.1A patent/EP1997827B1/en not_active Not-in-force
- 2007-02-28 ES ES07711101.1T patent/ES2441441T3/es active Active
- 2007-02-28 WO PCT/CU2007/000007 patent/WO2007098716A1/es active Application Filing
- 2007-02-28 MX MX2008011142A patent/MX2008011142A/es active IP Right Grant
- 2007-02-28 RU RU2008138569/10A patent/RU2416618C2/ru not_active IP Right Cessation
-
2008
- 2008-08-19 ZA ZA200807162A patent/ZA200807162B/xx unknown
- 2008-09-29 NO NO20084118A patent/NO20084118L/no not_active Application Discontinuation
-
2016
- 2016-06-24 CL CL2016001648A patent/CL2016001648A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007098716A1 (es) | 2007-09-07 |
AU2007219569B2 (en) | 2012-03-15 |
MY184130A (en) | 2021-03-19 |
KR20080110763A (ko) | 2008-12-19 |
AR059646A1 (es) | 2008-04-16 |
EP1997827A1 (en) | 2008-12-03 |
JP5183496B2 (ja) | 2013-04-17 |
RU2008138569A (ru) | 2010-04-10 |
CA2637593C (en) | 2015-04-14 |
WO2007098716A8 (es) | 2008-12-18 |
CL2007000528A1 (es) | 2008-01-18 |
CN101432294B (zh) | 2013-09-11 |
ES2441441T3 (es) | 2014-02-04 |
MX2008011142A (es) | 2008-09-08 |
JP2009528303A (ja) | 2009-08-06 |
NO20084118L (no) | 2008-09-29 |
EP1997827B1 (en) | 2013-10-09 |
CA2637593A1 (en) | 2007-09-07 |
BRPI0708366A2 (pt) | 2011-05-24 |
CN101432294A (zh) | 2009-05-13 |
ZA200807162B (en) | 2009-06-24 |
US20100055118A1 (en) | 2010-03-04 |
CU23558A1 (es) | 2010-07-20 |
RU2416618C2 (ru) | 2011-04-20 |
AU2007219569A1 (en) | 2007-09-07 |
KR101409277B1 (ko) | 2014-06-24 |
US8367620B2 (en) | 2013-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016001648A1 (es) | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento; composición farmacéutica y veterinaria que los comprende; método para inducir cardioprotección, neuroprotección, control del apetito, y método para estimular el crecimiento y resistencia a enfermedades en organismos acuáticos. (divisional de solicitud 2007-00528). | |
NZ603445A (en) | Gip-based mixed agonists for treatment of metabolic disorders and obesity | |
WO2014134225A3 (en) | Formulations comprising nutritive polypeptides and methods for treating cachexia, sarcopenia and muscle atrophy | |
GT201000160A (es) | Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales | |
BRPI1009846A2 (pt) | Processos para recuperar um agente de fermentação contendo proteína e uma composição de ração animal, e para tratar um resíduo de destilação total, composição de ração animal, aparelho para produzir etanol e um agente de fermentação contendo proteína, composição contendo proteína ,e, método estimular o crescimento em um animal | |
UY28757A1 (es) | Compuestos de pirazolina substituidos, su preparación y su uso como medicamentos | |
CL2011003173A1 (es) | Análogo del glucagón, agonista gip y glp-1; dímero que comprende el análogo de glucagón; conjugado con el análogo; composición que comprende dicho análogo; uso para preparar un medicamento para tratar diabetes, reducir el aumento de peso o inducir la pérdida de peso. | |
CL2007002121A1 (es) | Compuestos derivados de pirazoles, activadores de glucoquinasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que comprende dichos compuestos; y uso para el tratamiento de enfermedades y/o trastornos metabolicos, tal como diab | |
CL2008001114A1 (es) | Compuestos derivados de bencimidazol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como vejiga sobreactiva, dolor, obesidad, convulsiones, entre otras. | |
PE20121393A1 (es) | Analogo peptidico de oxintomodulina | |
NI201000044A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
MX2010003606A (es) | Modulacion antisentido de la expresion del receptor del factor de crecimiento fibroblastico 4. | |
CL2007003726A1 (es) | Anticuerpos anti-receptor del factor del crecimiento similar a la insulina i (igf-ir); composicion farmaceutica que lo contiene; y su uso para tratar el cancer. | |
CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
WO2009009727A3 (en) | Ghrh analogs and therapeutic uses thereof | |
AR080884A1 (es) | Conjugados de insulina-sirna | |
BR112012013868A2 (pt) | composição, proteína de fusão, polinucelotídeo, vetor ou constructo de gene, célula hospedeira , composição farmacêutica, método in vitro e uso de uma composição. | |
CL2015000462A1 (es) | Composición fungicida y método para el control de las enfermedades de las plantas. | |
NI201200134A (es) | Polipéptidos agonistas que se enlazan a dr5 | |
GT200500113A (es) | Derivados de pirimidina para tratar el crecimiento celular anomalo | |
CL2008002545A1 (es) | Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor. | |
NI201000015A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
CL2008002291A1 (es) | Compuestos derivados del acido 4-fluor-benzoico, inhibidores de la polimerasa hcv, composicion farmaceutica, kit farmaceutico y su uso para el tratamiento de una infeccion viral por hepatitis c. | |
CL2013000876A1 (es) | Composicion vacunal para el control de las infestaciones por ectoparasitos que comprende un peptido de la proteina ribosomal p0 de dichos ectoparasitos; uso de la composicion para preparar medicamento efectivo para control de las infestaciones por garrapatas y/o piojos de mar y/o la transmision de sus patógenos asociados. | |
GT201500168A (es) | Polipéptidos estabilizados del factor de crecimiento tipo insulina |